miR p Is a Novel Prognostic Biomarker of Prostate Cancer

Slides:

Advertisements

Similar presentations

Treating the Developing versus Developed Brain: Translating Preclinical Mouse and Human Studies B.J. Casey, Charles E. Glatt, Francis S. Lee Neuron Volume.

Advertisements

Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.

MiR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells Mathieu Neault, Frédérick A. Mallette, Stéphane Richard Cell.

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.

Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer Seung Tae Kim, Hye-Lim Jang, Jeeyun Lee, Se Hoon Park, Young.

A Hole in the Heart Journal of Thoracic Oncology

Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive.

Volume 195, Issue 4, Pages e13-e14 (April 2016)

Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Laparoscopic Versus Open Radical Nephrectomy for Renal Cell Carcinoma: a Systematic Review and Meta-Analysis Gang Liu, Yulei Ma, Shouhua Wang, Xiancheng.

Increased Oxidative Stress in the Proximal Stomach of Patients with Barrett’s Esophagus and Adenocarcinoma of the Esophagus and Esophagogastric Junction

P. Sooriakumaran, R. Kaba International Journal of Surgery

Expression of SOCS1 and CXCL12 Proteins in Primary Breast Cancer Are Associated with Presence of Circulating Tumor Cells in Peripheral Blood Bozena Smolkova,

Anti–Programmed Cell Death (PD)-1 Immunotherapy for Malignant Tumor: A Systematic Review and Meta-Analysis Ran Chen, Pei-Chun Peng, Bin Wen, Fu-Ying.

Volume 60, Issue 5, Pages (November 2011)

Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD Journal of Thoracic Oncology

Can Imaging Parameters Provide Information Regarding Histopathology in Head and Neck Squamous Cell Carcinoma? A Meta-Analysis Alexey Surov, Hans Jonas.

A Comparative Performance Analysis of Multispectral and RGB Imaging on HER2 Status Evaluation for the Prediction of Breast Cancer Prognosis Wenlou Liu,

Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension

Prostate Cancer Epidemic in Sight?

Volume 1, Issue 1, Pages (June 2007)

The Path(way) Less Traveled: A Pathway-Oriented Approach to Providing Information about Precision Cancer Medicine on My Cancer Genome Alexandria D. Taylor,

Analysis of PI3K/mTOR Pathway Biomarkers and Their Prognostic Value in Women with Hormone Receptor–Positive, HER2-Negative Early Breast Cancer Hamdy.

Characterization of Aurora A and Its Impact on the Effect of Cisplatin-Based Chemotherapy in Patients with Non–Small Cell Lung Cancer Peng Kuang, Zuhua.

Volume 184, Issue 4, Pages (October 2010)

NFATc1 Expression as a Prognosticator in Urothelial Carcinoma of the Upper Urinary Tract Takashi Kawahara, Satoshi Inoue, Kazutoshi Fujita, Taichi Mizushima,

Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A

Volume 1, Issue 6, Pages (December 2013)

Prostate Cancer Epidemic in Sight?

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Biostatistics Primer: What a Clinician Ought to Know—Prognostic and Predictive Factors Lorinda Simms, MSc, P Stat, Helen Barraclough, MSc, Ramaswamy.

Volume 50, Issue 5, Pages (November 2006)

Joachim Pfannschmidt, MD, Hans Hoffmann, MD, Hendrick Dienemann, MD

NA Journal of Thoracic Oncology

Electronic Updates for JTO Readers

Timing of Local and Distant Failure in Resected Lung Cancer: Implications for Reported Rates of Local Failure Jessamy A. Boyd, MD, Jessica L. Hubbs,

Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller Jung-Jyh Hung, MD, PhD, Yi-Chen Yeh, MD, Yu-Chung Wu,

Frank Detterbeck, MD Journal of Thoracic Oncology

The Bony Side of Endothelial Cells in Prostate Cancer

A Combined Prognostic Serum Interleukin-8 and Interleukin-6 Classifier for Stage 1 Lung Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening.

Tamas F. Molnar, Cengiz Gebitekin, Akif Turna

LAG-3 Protein Expression in Non–Small Cell Lung Cancer and Its Relationship with PD- 1/PD-L1 and Tumor-Infiltrating Lymphocytes Yayi He, MD, PhD, Hui.

A Hole in the Heart Journal of Thoracic Oncology

PD-L1 as a Companion Biomarker for Immune Checkpoint Inhibitors in NSCLC: Should RNA ISH (RISH) Be Considered? Steven G. Gray, PhD Journal of Thoracic.

Volume 4, Issue 2, Pages (June 2018)

Hui Cai, Jian-Lin Liu Journal of Vascular Surgery

Vamsidhar Velcheti, MD Journal of Thoracic Oncology

Colorectal Cancer Screening: How to Stop a Moving Target

Mirror Mirror on the Wall, Who Is the Fairest of Them All

EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas

Volume 69, Issue 12, Pages (June 2006)

Molecular Therapy - Nucleic Acids

Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients Line Brøndum, Jesper Grau Eriksen, Brita Singers Sørensen,

Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

The Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Lung Cancer: Still Following the Right TRAIL? Emmet E. McGrath, MB, PhD Journal of Thoracic.

Daniel Mønsted Shabanzadeh, Lars Tue Sørensen, Torben Jørgensen

News & Notes Journal of Allergy and Clinical Immunology

European Lung Cancer Conference (ELCC) 2016 Organisation

Table of Contents Nurse Leader Volume 16, Issue 3, (June 2018)

Volume 138, Issue 6, Pages (May 2010)

Covering the Cover Gastroenterology

Volume 2, Issue 6, Pages (June 2017)

Liseth L. van den Berg, MD, Theo J. Klinkenberg, MD, Harry J. M

Epidemiology of Thymoma and Associated Malignancies

Clinical and Translational Radiation Oncology

A Review of First-Line Treatment for Small-cell Lung Cancer

A. Carlson, B. Bothner, R. June Osteoarthritis and Cartilage

Presentation transcript:

miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer Dibash K. Das, Joseph R. Osborne, Hui-Yi Lin, Jong Y. Park, Olorunseun O. Ogunwobi Translational Oncology Volume 9, Issue 3, Pages 236-241 (June 2016) DOI: 10.1016/j.tranon.2016.04.005 Copyright © 2016 The Authors Terms and Conditions

Figure 1 Cumulative incidence of PCa death by miR-1207-3p expression level (P = .062). Translational Oncology 2016 9, 236-241DOI: (10.1016/j.tranon.2016.04.005) Copyright © 2016 The Authors Terms and Conditions

Figure 2 Cumulative incidence of PCa recurrence by miR-1207-3p expression level (P < .001). Translational Oncology 2016 9, 236-241DOI: (10.1016/j.tranon.2016.04.005) Copyright © 2016 The Authors Terms and Conditions